Enalapril and treadmill running reduce adiposity, but only the latter causes adipose tissue browning in mice

J Cell Physiol. 2021 Feb;236(2):900-910. doi: 10.1002/jcp.29900. Epub 2020 Jul 2.

Abstract

This study investigated whether regulation of the renin-angiotensin system (RAS) by enalapril and/or aerobic exercise training (AET) causes browning of the subcutaneous white adipose tissue (sWAT). C57BL/6 mice were fed either a standard chow or a high-fat (HF) diet for 16 weeks. At Week 8, HF-fed animals were divided into sedentary (HF), enalapril (HF-E), AET (HF-T), and enalapril plus AET (HF-ET) groups. Subsequently, sWAT was extracted for morphometry, determination of RAS expression, and biomarkers of WAT browning. The HF group displayed adipocyte hypertrophy and induction of the classical RAS axis. Conversely, all interventions reduced adiposity and induced the counterregulatory RAS axis. However, only AET raised plasma irisin, increased peroxisome proliferator-activated receptor-γ coactivator-1α, and uncoupling protein-1 levels, and the expression of PR-domain containing 16 in sWAT. Therefore, we concluded that AET-induced sWAT browning was independent of the counterregulatory axis shifting of RAS in HF diet-induced obesity.

Keywords: aerobic exercise training; browning; renin-angiotensin system; white adipose tissue.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue, Brown / drug effects*
  • Adipose Tissue, Brown / metabolism
  • Adipose Tissue, Brown / physiopathology*
  • Adipose Tissue, White / metabolism
  • Adipose Tissue, White / physiopathology
  • Adiposity / drug effects*
  • Animals
  • Biomarkers / metabolism
  • Diet, High-Fat / adverse effects
  • Enalapril / pharmacology*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Obesity / metabolism
  • Obesity / physiopathology
  • Physical Conditioning, Animal / physiology*
  • Renin-Angiotensin System / drug effects
  • Running / physiology*
  • Subcutaneous Fat / drug effects*
  • Subcutaneous Fat / metabolism
  • Subcutaneous Fat / physiopathology

Substances

  • Biomarkers
  • Enalapril